Faculty profile
Sophie Stock-Martineau
Back to facultyResearch
Read how they describe their research on their Université de Montréal profile.
Latest papers
EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2021 · first author
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
Blood · 2009
2 publications.
EGFR Tyrosine Kinase Inhibitor Monotherapy Should Remain the Standard First-Line Treatment in Advanced EGFR-Mutant NSCLC.
Stock-Martineau S, Shepherd FA
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties
François M, Romieu-Mourez R, Stock-Martineau S, Boivin M-N, Bramson JL, Galipeau J
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.